share_log

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K：重大事件
美股sec公告 ·  06/27 16:09
Moomoo AI 已提取核心信息
On June 23, 2024, Novo Integrated Sciences, Inc. amended a securities purchase agreement with Streeterville Capital, LLC. The amendment, referred to as the First Amendment, modifies the original agreement made on April 5, 2024, where Novo Integrated Sciences issued a secured convertible promissory note to Streeterville with a principal sum of $6,210,000 and a maturity date of April 8, 2025. The First Amendment allows the registration statement for at least 3,500,000 shares of common stock for Streeterville to be filed on Form S-1 or S-3 by July 3, 2024. Additionally, Streeterville waived any potential breaches or defaults by Novo Integrated Sciences related to the timely filing of the Registration Statement as of June 23, 2024. This information was disclosed in a Current Report on Form 8-K filed with the SEC, which includes the full text of the First Amendment as Exhibit 10.1.
On June 23, 2024, Novo Integrated Sciences, Inc. amended a securities purchase agreement with Streeterville Capital, LLC. The amendment, referred to as the First Amendment, modifies the original agreement made on April 5, 2024, where Novo Integrated Sciences issued a secured convertible promissory note to Streeterville with a principal sum of $6,210,000 and a maturity date of April 8, 2025. The First Amendment allows the registration statement for at least 3,500,000 shares of common stock for Streeterville to be filed on Form S-1 or S-3 by July 3, 2024. Additionally, Streeterville waived any potential breaches or defaults by Novo Integrated Sciences related to the timely filing of the Registration Statement as of June 23, 2024. This information was disclosed in a Current Report on Form 8-K filed with the SEC, which includes the full text of the First Amendment as Exhibit 10.1.
2024年6月23日，Novo Integrated Sciences, Inc.修改了其与Streeterville Capital，LLC的证券购买协议。所谓的第一修正案修改了2024年4月5日签订的原始协议，Novo Integrated Sciences向Streeterville发行了一张担保可转换期票，面额为6,210,000美元，到期日为2025年4月8日。第一修正案允许在2024年7月3日之前以S-1或S-3表格递交至少3,500,000股普通股的注册声明。此外，截至2024年6月23日，Streeterville豁免了与Novo Integrated Sciences有关及时提交注册声明的任何潜在违约或违约。该信息在提交给SEC的8-K表格的当前报告中披露，其中包括第10.1展示文件的全部文本。
2024年6月23日，Novo Integrated Sciences, Inc.修改了其与Streeterville Capital，LLC的证券购买协议。所谓的第一修正案修改了2024年4月5日签订的原始协议，Novo Integrated Sciences向Streeterville发行了一张担保可转换期票，面额为6,210,000美元，到期日为2025年4月8日。第一修正案允许在2024年7月3日之前以S-1或S-3表格递交至少3,500,000股普通股的注册声明。此外，截至2024年6月23日，Streeterville豁免了与Novo Integrated Sciences有关及时提交注册声明的任何潜在违约或违约。该信息在提交给SEC的8-K表格的当前报告中披露，其中包括第10.1展示文件的全部文本。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息